What is the purpose of this study?The purpose of this study is to collect blood specimens and clinical data from adult patients (≥18 yrs.) presenting with signs and symptoms suggestive of acute bacterial or viral infection. These samples will be used to check how well MeMed BV™, a lab test, can tell the difference between bacterial and viral infections. We will compare the results using the Beckman Coulter Access 2 and DxI 9000 Immunoassay Analyzers to see how effective it is in diagnosing infections. This study will eventually help physicians to treat sick patients better and faster. THIS STUDY IS ENROLLING BY INVITATION ONLY - Potential participants with signs and symptoms suggestive of acute bacterial or viral infection will be approached as they present to the emergency department by their doctor and research team about study participation. The consent process and research procedures will occur during the subjects regularly scheduled clinic visit in a private room..

What is the purpose of this study?This phase II trial tests how well nivolumab in combination with chemotherapy drugs along with radiation therapy works in treating patients with nasopharyngeal cancer. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Researchers want to find out what effects, good and/or bad, adding nivolumab to chemotherapy has on patients with newly diagnosed NPC. In addition, they want to find out if children with NPC may be treated with less radiation therapy and whether this decreases the side effects of therapy.THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic. Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:IU Clinical Trials Office Email: iutrials@iu.eduPhone: (317) 278-5632

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.

What is the purpose of this study?The purpose of this study is to collect female reproductive tract tissues to investigate the key molecular events regulating endometriosis. Our central hypothesis is that by using well-characterized tissues, we can create novel models to improve treatments for endometriosis. THIS STUDY IS ENROLLING BY INVITATION ONLY - Women with suspected endometriosis (pelvic pain, adnexal mass, infertility), endometrial cancer, or ovarian cancer who are undergoing surgery for one of these diseases will be identified by her primary surgeon. For non-endometriosis control patients, these women will be selected based on a diagnosis of menorrhagia or symptomatic uterine fibroids or pelvic organ prolapse. All patients will be approached for recruitment only after agreeing to surgery. No surgery will be performed for the sole purpose of this study.